Recent advancements in molecular biology in the field of taste perception in the oral cavity have raised the possibility for ingested nutrients to be "tasted" in the upper gastrointestinal tract (GI). The purpose of this study was to identify the existence of a nutrient-sensing system by the vagus in the rat stomach. Afferent fibers of the gastric branch increased their firing rate solely with the intra-gastric application of the amino acid glutamate. Other amino acids failed to have the same effect. This response to glutamate was blocked by the depletion of serotonin (5-HT) and inhibition of the serotonin receptor 3 (5-HT 3 ) or nitric oxide synthase enzyme (NOS). Luminal perfusion with a local anesthesia lidocaine abolished the glutamate-evoked afferent activation. The afferent response was also mimicked by luminal perfusion with a NO donor, sodium nitroprusside. In addition, the NO donor-induced afferent activation was abolished by 5-HT 3 blockade as well. Altogether, these results strongly suggest the existence of a sensing system for glutamate in the rat gastric mucosa. Thus, luminal glutamate would enhance the electrophysiological firing rate of afferent fibers from the vagus nerve of the stomach through the production of mucosal bioactive substances such as NO and 5-HT. Assuming there is a universal co-existence of free glutamate with dietary protein, a glutamate sensing system in the stomach could contribute to the gastric phase of protein digestion.
Introduction
The number of articles dedicated to the abdominal vagus nerve that were focused in gut nutrient sensing has increased dramatically over the last decade (33, 36, 42) . This is due to the advancement of techniques that facilitated the study of visceral afferent fibers, their function and characteristic electrophysiological patterns; and also because it has been recognized that they are important for body nutrient homeostasis. Psychophysiological approaches for the understanding of ingestive behavior have demonstrated that the presence of food in the upper gastrointestinal tract plays a critical role in determining meal size. The vagus nerve is extensively distributed throughout the GI tract, from the posterior region of oral cavity and esophagus to the lowest part of the colon; and functions as the primary neuroanatomical circuit in the gut-brain axis to transmit meal-related signals from the gastrointestinal mucosa to the central nervous system. This is where regulatory processes (e.g., ingestive behavior, nutrient absorption, GI secretion, and stomach emptying) as well as conscious sensations (e.g., satiety, nausea and discomfort) take place (5, 22, 37) .
Recently, it has been shown that taste transduction-related molecules, such as -gustducin and a family of bitter-sensing taste receptors (T 2 Rs), were also expressed at the gastrointestinal mucosa (14, 46) suggesting that taste receptors could be possibly involved in gut nutrient sensing. Likewise, receptors for well-known gut hormones (i.e., 5-HT,
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5 cholecystokinin [CCK] and VIP) are also expressed in taste buds of the oral cavity, and it has been proposed that those gut hormones could modulate taste perception too (13, 15, 16, 38 Taking all these observations together, it seems as if the tongue and the upper gastrointestinal tract share common systems for nutrient sensing.
We have been the first to find that the gastric branch of the vagus nerve in the rat responded to the intra-gastric administration of the monosodium salt of glutamic acid, which is a major component of many proteins in foodstuffs (26,27) ; and that leaded us to hypothesize that the stomach could "taste" ingested nutrients through a chemical sensing systems similar to the one functioning in the tongue and intestine. The novelty of this conjecture resides in the fact that, to date, the gastric wall has been only considered to be able to detect meal volume by mechanical stretch; whereas nutrients, indicators of meal quality, were assumed to be mainly recognized at the intestine mucosal wall which chemical information would need to be transported to the brain through the afferent fibers of the vagus nerve. A variety of data support this vago-vagal reflex elicited by the intestinal mucosa chemoperception (2, 21, 23, 26) . However, besides this work, no reports were found in relation to the existence of gastric mucosal chemical sensors linked to the vagus nerve electrophysiological stimulation to our knowledge. Carbohydrate (glucose) and lipid (fatty acids) chemical perception in the gut, where the intercellular cross-talk conveys the luminal nutrient signal to the vagus nerve, was clearly demonstrated for the duodenal wall (19, 47) . On 6 the other hand, nobody has shown until now the mechanisms at work for the gastric chemical sensing of amino acids at the stomach mucosa. In this paper, we show that the electrophysiological response of afferents from the gastric branch of the vagus nerve were specifically activated in response to glutamate on the rat gastric mucosa via an intrinsic cascade involving NO and 5-HT. As a result, we proposed a new hypothesis based on the gastric perception of the free glutamate that is found in foodstuffs. 
Materials & Methods
Animal preparation
Male Sprague-Dawley rats, weighing around 250-330 g, were used for this experiment. Rats were housed under controlled temperature (23 C) and light-cycle (lights on between 07:00-19:00), and were fasted for 18 hr with free access to tap water before surgery. The surgical techniques and other experimental methods are documented extensively elsewhere (26, 41) . Under urethane anesthesia (1 g/kg, i.p.), the left carotid artery was cannulated with a heparinized polyethylene catheter (200 U/ml heparin in saline) to monitor blood pressure, while the left femoral vein was cannulated for drug administrations. After the pylorus of the stomach was closed with silk suture, a polyethylene catheter was inserted into the fundus. A balloon (15 mm x 13 mm; Physio-Tech, Tokyo, Japan) connected to the catheter was inserted into the stomach from the esophagus to measure distension-evoked vagal responses. Solutions for the intra-gastric perfusion experiment were applied at a flow rate of 1 mL/min with a peristic pump through a catheter inserted into the fundus. The output was captured by another catheter placed through the pylorus. All solutions were kept at 37 C during gastric perfusion.
Under a dissection microscope (Olympus SZX12, Tokyo, Japan), the nerve bundle of the left gastric branch was split with a sharp blade leaving a length of about 3 mm. Fine vagal filaments were dissected from the main nerve trunk and placed on a silver hook recording electrode. The perineural connective tissue was placed on a reference electrode. All 8 recordings were made from the peripheral cut end of the vagal nerve still innervating the stomach. The abdominal wound was covered with a saline-moisturized gauze, and rats maintained at 37 C over a heating pad (BWT-100, BRC, Nagoya, Japan).
Electrophysiological recordings.
The electrode was connected to a head stage (JB-101J, Nihon-Koden, Tokyo, Japan) and the signal differentially amplified 10,000 times before being filtered with a bandwidth of 150
Hz to 1 KHz (SEN-6000, Nihon-Koden, Japan). The neural signal out-put, together with the signal from the pressure transducer, were acquired by a power lab interface (Powerlab, ADI instruments, UK) and viewed online by a Machintosh-running Chart software. The nerve signal was digitally sampled at 4 kHz, which was sufficient to allow spike discrimination.
Nerve activity was analyzed either by conversion of raw data to standard pulses and counted (5-s bin width), or by an integration of the raw data with a 1s time constant using an off-line software such as spike histogram extension (SHE; ADI instruments) and Spike 2 (Cambridge Electronic Design, UK). Data were also recorded on tape for later analysis. Afferent nerve activities were characterized in terms of average discharge frequency (spikes/s, 5-s bin width).
Baseline discharge was determined over 4 min period just before drug administrations, whereas the maximum response was determined as the increase in discharge above baseline during a 5-s period identified as the peak in afferent nerve activity in a sequential rate 
Experimental protocol
After 15 min baseline recording for signal stabilization, the variability of the afferent activity was assessed with a bolus injection of 10 µg/kg 5-HT (i.v.). Afferent nerves that failed to respond to the 5-HT stimuli were discarded. All experiments were performed at least 20 min after checking for 5-HT response. Baseline discharge was determined over a period of 4 min just before starting each experiment. For the mechanical response study, each stimulus (1 to 4 mL) was applied at a rate of 0.1 mL/ sec with 20 min interval, the maximal increases in discharge rate above baseline within 2 min (Peak) and the mean discharge rate at 10 min (Stable) just after gastric distension was measured. For nutrient response studies, each amino acid (2 mL) was injected at a flow rate of 0.1 mL/sec. Glutamate response appeared to be a biphasic one. This consisted of an initial transient increase in discharge rate above the baseline (primary rise), within 2 min of the response, that was followed by a long-lasting activation (secondary rise). The mean discharge rate that increased above the baseline 20 min after the onset of the experiment was considered as a secondary rise index. For the intra-gastric perfusion study, each perfusate was applied at a flow rate of 1 mL/min while monitoring intra-gastric pressure. Before experiments were started, we estimated the intra-gastric effects of various pHs (saline at a pH of 5, 6 or 7 adjusted with 0.05N HCl or 10 NaOH) and osmolarities (10, 150, 450 and 1000 mmol/L NaCl solutions) on the gastric afferent activities. The average discharge rates of pH 5, 6 and 7 were 9.5 ± 0.7, 9.9 ± 0.6 and 9.6 ± 0.8 spikes/sec, respectively (n=3). The rates of 10, 150, 450, 1000 mmol/L NaCl were 10.0 ± 0.5, 9,8 ± 0.6, 9.5 ± 0.6, 9.8 ± 0.9, 9.4 ± 0.4 spikes/sec (n=3).
Nutrients and chemical agents.
All amino acids were made in Ajinomoto Co., Inc. (Tokyo, Japan). Hydrochloride salts of basic amino acids (lysine and arginine) and monosodium salts of acidic amino acids (glutamic acid and aspartic acid) were used for the present experiment. The pH of each amino acid solution (150 mmol/L) was between 5.2 and 6.9. Chemical agents such as serotonin (5-HT), sodium nitroprusside (SNP), SB39604 hydrochloride, cimetidine chloride, atropine chloride, lidocaine, and p-chlorophenylalanine (PCPA) were purchased from Sigma, and N( )-nitro-1-arginine methyl ester (L-NAME) was purchased from Tocris. Granisetron was from Chugai Pharmaceutical (Osaka, JAPAN). All chemicals except SB39604 and PCPA were dissolved in a saline solution just before experiments. SB39604 was dissolved in ethanol (10mg/mL; stock solution) and PCPA suspended in 0.5% carboxy-methy-cellulose (CMC)-Na.
Statistics
Data were expressed as mean SEM (n = number of animals). The half-maximal inhibitory dose was estimated by a conventional least-squares fitting procedure to a mirror image of Michaelis-Menten equation. Analysis of variance was performed by using non-parametric tests such as the Wilcoxon signed-rank test or the Kruskal-Wallis test, as appropriate. A probability of P < 0.05 was considered statistically significant.
Results
Vagal afferent activation by gastric distension
First, we recorded the responses from the afferents of the ventral gastric vagus specifically responsible for distension. Gastric distension was achieved by filling a balloon catheter inserted into the stomach with a saline solution (1 to 5 mL). This stretch stimulus evoked a monophasic vagal afferent activation in a volume-dependent manner (Fig.1A) . The half-maximal effective volume for a peak response was 1.64 mL. The distension-induced increase of the vagal firing rate declined exponentially to basal firing rates even after maintaining the distension stimuli. When the injected volume was below 2 mL, the afferent whereas from the onset to the secondary activation the interval was of 507 ± 66 s respectively (n=5) which continued for more than 1 hr before returning to the baseline. The concentration-dependent response to glutamate at the secondary afferent reaction was summarized in the figure 2B. This shows that afferent discharge rates above baseline were dose-dependently increased 20 min after each dose of glutamate application (50, 150 and 450 mmol/L). We also examined whether a low concentration of glutamate (10 mmol/L) was able to evoke the activation of gastric afferents. And without a doubt, a slight increase in the vagal afferent discharge was observed even at this low dose of glutamate (10 ± 0.6 and 18.3 ± 3.3 spikes/sec for pre-and post-glutamate application, respectively) (n=4; p<0.05, Wilcoxon signed rank test). Therefore, the threshold concentration for glutamate has to be below this amount of 10 mmol/L. In contrast to luminal application, the intravenous administration of glutamate failed to increase the afferent discharge at a dose of 30 mg/kg (data not shown; Receptor pharmacology involved in the luminal glutamate-triggered afferent response.
The secondary phase, the glutamate specific response, was selectively attenuated by either the pre-or post-treatment with the 5-HT 3 antagonist granisetron (Fig. 4A&B) . However, granisetron could not inhibit the first phase in the afferent response which was the result of gastric distension (28.6 ± 6.9 spikes/s in control rats and 26.1 ± 8.5 spikes/s in 10 µg/kg granisetron-treated rats; n=5). Intravenously, granisetron (10 µg/kg) inhibited the secondary glutamate specific response by 76.6 ± 5.8 % and its half-maximal inhibitory dose was 0.23 ± 0.10 µmol/kg (n=4; It has been shown that nitric-oxide synthases as well as 5-HT are densely distributed in the upper gastrointestinal tract (7,31). As a result, the effect of a non-selective NOS inhibitor, L-NAME, was studied to evaluate if NO was involved in the vagal glutamate response. Figure   6A shows that L-NAME (10 mg/kg, i.v.) influenced the luminal glutamate-induced vagal afferent response and arterial blood pressure as well. The last one, blood pressure, rapidly increased by about 41 mmHg within 10 min after the administration of L-NAME ( 98 ± 6.1 to 139 ± 10 mmHg; n=3; p<0.05, Wilcoxon signed rank test). Under these experimental Nevertheless, in contrast to the activation observed for glutamate, the effect of L-NAME itself or the blockade of intrinsic NO release did not affect directly the response of gastric vagal afferent to 5-HT. Vagal afferents reacted to an intravenous bolus of 5-HT (10 µg/kg) with 37.6 ± 7.5 spikes/sec prior to L-NAME treatment. Fifteen minutes after the intravenous injection of L-NAME (10 mg/kg) response of afferents was 47.8 ± 14.9 spikes/sec (n=3).
(Figures 5 and 6 near here)
Effects of intra-gastric perfusion with NO donor and 5-HT on the gastric afferents.
To verify that mucosal NO itself could trigger gastric vagal activation, we examined the
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18 luminal effect of a NO donor, sodium nitroprusside (SNP), on gastric afferents. We could prove first that the intra-gastric luminal perfusion of 100 µg/mL SNP evoked the afferent activation of the gastric ventral vagal nerves (Fig. 7A) and that an intravenous injection with granisetron (10 µg/kg) was able to abolish these SNP-evoked afferent discharges as well.
Since the perfusion of the stomach lumen with 300 µg/mL 5-HT could not activate directly the gastric afferent nerve (Fig. 7B) , altogether data strongly indicate that the mucosal generated NO acts indirectly over the vagal afferent fibers through the mobilization of 5-HT within the gastric mucosa.
( Figure 7 near here)
Effect of luminal perfusion of local anesthetic on the glutamate response
To reconfirm that the luminal glutamate-evoked afferent activation was the metabolic event within the gastric mucosa, we tested the effect that the luminal perfusion with a local anesthetic (lidocaine) had on the glutamate response. The protocol of the experiment, as shown in figure 8 , consisted on an initial perfusion of 150 mmol/L glutamate that was quickly changed after 10 min to a glutamate solution containing 10 mmol/L of lidocaine. In the stomach, lidocaine depressed the glutamate response in a time-dependent manner, so that after 20 min, glutamate response was down to 80% (n=3). We showed elsewhere that the discharges of afferent fibers induced by 5-HT (10 µg/kg, i.v.) were also depressed by the application of lidocaine over the mucosa of the stomach without affecting the stretch-gated afferent nerve component (41) . Thus, the luminal glutamate sensing by the gastric vagus seemed to be a local event within the gastric mucosa. According to our experimental conditions in the current study, distension-and glutamate-mediated components of the afferent responses from the gastric branch of the vagus nerve were clearly discriminated. The distension-induced electrophysiological stimulation of the vagus nerve was transient with an exponential decay (Fig. 1) , and also insensitive to the 5-HT 3 receptor antagonist granisetron. Whereas, the intra-gastric administration of glutamate solution evoked a long-lasting nerve discharge followed by a rapid transient component (Fig.   2 ). That first transient component was not inhibited by granisetron, but the receptor antagonist did strongly block the secondary long-lasting component instead (Fig. 4) . Thus, the Neurons that innervate the lining of the stomach can produce at the same time NO and 5-HT, which regulates gastric motility as well as gastric acid secretion through the modulation of intrinsic nerve activity (18, 20, 40) . Nonetheless, neurons are not the only source of these bioactive molecules. There is also a large amount of non-neuronal 5-HT and NO in the gastric mucosa itself (4,30,31), and we feel that the physiological roles for those molecules in the stomach have not been clearly identified yet. This current report suggests that gastric non-neuronal 5-HT and NO can act in the stomach mucosa as paracrine substances as well after the recognition of nutrients, such as an amino acid like glutamate, in a process similar to the one reported for the duodenal glucose-sensing (47) . In addition, mucosal NO has been implicated in different components of gastric mucosal defense, including increases of the mucosal blood flow and mucin secretion, activation of mucosal immune cells, and repair of the epithelia after injuries caused during digestion (3, 7) . Furthermore, it is thought that the diffusion of NO within the mucosa or into its basal microvessels might be effective in local disinfection or in the maintenance of microcirculation because of its anti-platelet effect. Thus, non-neuronal 5-HT and NO in the gastric mucosa might also regulate gastric digestion, by acting as a transmitter for vagal amino acid-sensing and a paracrine hormone.
Present observations strongly point out the direct or indirect serotonin-containing cell In the regard for glutamate, its physiological function in the gastrointestinal tract (GI) has started to be investigated. For instance, we know now that oral intake of monosodium glutamate stimulates exocrine secretion (saliva and gastric, bile and pancreatic juices) (28,29,33,39,43) as well as the GI endocrine system such as insulin (11) . Moreover, the infusion of monosodium glutamate into the stomach directly evokes a gastric vago-vagal reflex accompanied by insulin secretion (27). These reports strongly suggest that not only gastric but also taste stimulation by glutamate might be, in part, involved in those cephalic responses.
On the gut chemical perception, Fujita and collaborators originally proposed the paraneuron-hypothesis which claims the existence of neuron-like cells that can sense nutrients from the foodstuffs and send signals in response (9) . This hypothesis was based on the histochemical observation in which gut endocrine cells were bipolar cells extending an apical process to the gut lumen and releasing their messenger substances from the cell base in response to the apical stimuli. These bipolar endocrine cells could be also observed in the gastric antrum, but their possible involvement in the chemical perception of nutrients by the vagus has never been discussed. Afferent fibers from the gastric branch of the vagus nerve increase their electrophysiological activity only at the intra-gastric application of glutamate, not with any of the remaining amino acids tested (Fig. 3) . This seems to be specific for the chemical amino acid sensing in the stomach since it has been well documented that fibers from the celiac nerve could respond to almost all of amino acids applied into the duodenum (23). What are the candidate molecules for sensing glutamate at the surface of the stomach?
At the oral cavity, several glutamate-sensing receptors have been identified (T 1 R 1 /T 1 R 3
heterodimer, ionotrophic and different variants various metabotrophic glutamate receptors) (6, 25, 35) , but it is still unknown whether those molecules are expressed on the rat gastric mucosa. In the present experiment, a potent agonist for the NMDA receptor, aspartic acid, failed to stimulate the vagal afferent fibers from the gastric branch (Fig.3) . This suggests that the NMDA receptor is not be involved in this vagal response. We need to look further into the As summary, we showed in this work that glutamate at the surface of the stomach could evoke a mucosal chemical cascade led by NO release and followed by 5-HT to trigger at the end a post-prandial visceral sensation, which probably regulates food intake and digestion. It seems that glutamate in the GI tract could be "tasted" at the surface of the stomach. Our proposed regulatory pathways may help to specify the role of glutamate to maintain body nutrition homeostasis through the regulation of the vagus nerve electrophysiological activity at the afferent terminal fibers that innervates the GI tract. Gl utamate is one of the most abundant amino acids in plant and meat protein foodstuffs, and it is found in a free form which co-exists with those proteins at relatively high concentrations. After tomatoes ripe or cheese fermentation takes place, the content of glutamate can reach up to, or more than 20 mmol/L; whereas traditional seasonings such as soy and oyster sauce contain more than 60 mmol/L of glutamate (10, 44) . Under the assumption that 10 mmol/L of glutamate was enough to evoke a significant increase for the firing rate of afferent nerve fibers, it could be realistically considered that the electrophysiological activation of the terminal afferent nerve endings that innervate the stomach mucosa could occurred under the influence of an habitual daily meal. We believe that the complete elucidation for the physiological role of gastric Each perfusate was applied at a flow rate of 1 mL/min. Granisetron (GRN) was applied intravenously at a dose of 10 µg/kg. Each recording was a typical of three reproducible observations. Fig. 8 . Effect of luminal perfusion with a local anesthesia on the glutamate response.
The perfusate was changed to the glutamate solution containing 10 mmol/L lidocaine 10 min after starting the luminal perfusion of 150 mmol/L glutamate. Each perfusate was applied at a flow rate of 1 mL/min. Each recording was a typical of three reproducible
